Hawkins Richard J

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$64,767.17
Insider Sells Quantity
2
Insider Sells Sum
$277,621.77

Insider Activity of Hawkins Richard J

According to the SEC Form 4 filings, Hawkins Richard J, being in a position of

  1. director at Plus Therapeutics, Inc.,
    оver the last 12 months, has bought 15187 shares for $24,508, and sold 0 shares,
    over all time since 2023-03-03, has bought 15188 shares for $25,508, and sold 0 shares.

The largest purchase of all time was on 2022-09-21 and amounted to 2214 shares of Lumos Pharma, Inc. for $19,572.

The largest sale of all time was on 2019-05-14 and amounted to 14591 share of Savara Inc. for $161,455.

Biography of Hawkins Richard J

No biography is available at this moment.

2024-09-13PurchasePlus Therapeutics, Inc.
PSTV
director
4,000
0.0687%
$1.50$5,996-8.11%
2024-09-12PurchasePlus Therapeutics, Inc.
PSTV
director
6,285
0.1009%
$1.35$8,512-4.9%
2024-05-08PurchasePlus Therapeutics, Inc.
PSTV
director
4,902
0.103%
$2.04$10,000-31.28%
2023-03-03PurchasePlus Therapeutics, Inc.
PSTV
director
1
–
$1,000.00$1,000-59.05%
2022-09-23PurchaseLumos Pharma, Inc.
LUMO
Chief Executive Officer
208
0.0024%
$8.80$1,830-61.56%
2022-09-21PurchaseLumos Pharma, Inc.
LUMO
Chief Executive Officer
2,214
0.0264%
$8.84$19,572-60.7%
2022-09-20PurchaseLumos Pharma, Inc.
LUMO
Chief Executive Officer
1,506
0.0178%
$8.75$13,178-60.59%
2022-09-19PurchaseLumos Pharma, Inc.
LUMO
Chief Executive Officer
541
0.0064%
$8.65$4,680-59.77%
2019-05-15SaleSavara Inc.
SVRA
director
10,409
0.0267%
$11.16$116,167-78.87%
2019-05-14SaleSavara Inc.
SVRA
director
14,591
0.038%
$11.07$161,455-78.37%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.